BioSig Tech (BSGM) Skyrockets 22% After Securing $1.1B Gold-Backed Blockchain Deal—Wall Street Scrambles

Blockchain meets bullion—and traders are piling in.

Gold gets a digital makeover

BioSig Technologies just turned heads with a $1.1 billion financing deal backed by physical gold and powered by blockchain. The stock surged 22% as markets woke up to the hybrid play—part old-school asset, part crypto innovation.

Why this matters

Forget meme stocks—this is real metal meeting distributed ledgers. The deal signals institutional appetite for asset-backed crypto plays, even as Bitcoin maximalists scoff at 'digitized boomer gold.'

The cynical take

Wall Street banks—who mocked crypto for years—are now quietly building blockchain teams faster than you can say 'hypocrisy.' Meanwhile, BSGM investors cheer the pump while gold bugs and crypto bros both claim victory. Everyone wins (until the SEC starts asking questions).

TLDR

• BioSig pivots to gold-backed blockchain, lands $1.1B in growth funding.
• BSGM surges as gold tokenization deal signals bold fintech transformation.
• BioSig to tokenize gold on Solana, eyes $16T RWA market by 2030.
• BSGM shifts from medtech to gold and blockchain in $1.1B mega deal.
• BioSig-Streamex merger fuels gold-backed blockchain finance revolution.

BioSig Technologies, Inc. (BSGM) surged to $14.00 in pre-market trading on July 8, reflecting a 21.21% gain. The stock had already closed 10.95% higher at $11.55 on July 7. The strong momentum followed the company’s announcement of a $1.1 billion growth financing deal tied to gold-backed blockchain initiatives.

BioSig Technologies, Inc. (BSGM)

The company entered into definitive agreements with a major institutional backer for $100 million in convertible debentures. Additionally, it secured a $1 billion equity line of credit, aimed at transforming BioSig into a major holder of physical gold. With this strategy, BioSig aims to combine blockchain innovation with the security of Gold to reshape commodity finance.

The financing deal is expected to close on October 7, 2025, pending shareholder and regulatory approvals. The first $75 million tranche of debentures will close initially, while the remaining $25 million will close later. The company plans to denominate most of its balance sheet in vaulted physical gold, moving away from fiat currency holdings.

BioSig and Streamex Join Forces to Drive RWA Tokenization in Commodities

Following a recent merger with Streamex Exchange Corporation, BioSig has pivoted towards blockchain-based real-world asset (RWA) tokenization. The new entity plans to lead the transition of the $142 trillion global commodities market onto blockchain rails. Streamex’s infrastructure will support tokenization of gold and other commodities for broader digital access.

The convertible debentures mature in 24 months and carry 4% annual interest, increasing to 18% upon default. BioSig will issue the debentures at 96% of face value, backed by a first-priority lien on certain company assets. The equity line enables the company to sell stock for up to $1 billion over 36 months, providing substantial capital access.

This MOVE signals a strategic shift from medical technology to financial innovation while still maintaining its PURE EP™ cardiac platform. The company now positions itself as a gold treasury firm with a blockchain edge. The plan includes filing a resale registration statement with the SEC to allow stock issuance from the deal.

Gold Holdings and Blockchain Tech Form Core of Growth Strategy

BioSig plans to hold large volumes of gold in allocated vaults via a top-tier bullion bank. The company intends to issue tokens backed by this gold using solana blockchain technology to generate revenue. These gold-related tokens will offer low-cost, secure access to the gold market while enabling flexible financing models.

Market data shows gold trading volume exceeds Bitcoin’s by 4.5 times, highlighting strong demand for gold-based financial products. BioSig aims to capitalize on this trend with a blockchain platform targeting a projected $16 trillion RWA tokenization market by 2030. This approach is designed to enhance liquidity and yield over traditional gold investments.

The leadership team includes executives with backgrounds at Rio Tinto, Credit Suisse, and Freeport McMoRan. Strategic advisors include Frank Giustra and Sean Roosen, who bring expertise from gold mining, blockchain, and financial markets. With this blend of physical assets and digital infrastructure, BioSig is targeting growth and disruption in global finance.